http://www.unboundmedicine.com/medline/ebm/research/selegilineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19890073/full_citation/Selegiline_and_oxidative_stress_in_HIV_associated_cognitive_impairment_Schifitto G, Yiannoutsos CT, Ernst T, et al. 
Selegiline and oxidative stress in HIV-associated cognitive impairment. [JOURNAL ARTICLE]
Neurology 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19879254/full_citation/Entacapone_a_catechol_O_methyltransferase_inhibitor_improves_the_motor_activity_and_dopamine_content_of_basal_ganglia_in_a_rat_model_of_Parkinson's_disease_induced_by_Japanese_encephalitis_virus_Hamaue N, Ogata A, Terado M, et al. 
Entacapone, a catechol-O-methyltransferase inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson's disease induced by Japanese encephalitis virus. [JOURNAL ARTICLE]
Brain Res 2009 Oct 28.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19855267/full_citation/Orally_Disintegrating_Selegiline_in_Parkinson_Patients_With_Dopamine_Agonist_Related_Adverse_Effects_Lyons KE, Friedman JH, Hermanowicz N, et al. 
Orally Disintegrating Selegiline in Parkinson Patients With Dopamine Agonist-Related Adverse Effects. [JOURNAL ARTICLE]
Clin Neuropharmacol 2009 Oct 22.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19821381/full_citation/Monoamine_oxidase_B_inhibitors_versus_other_dopaminergic_agents_in_early_Parkinson's_disease_Caslake R, Macleod A, Ives N, et al. 
Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease. [Journal Article]
Cochrane Database Syst Rev 2009; (4):CD006661.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19777340/full_citation/Regulation_of_Brain_Derived_Neurotrophic_Factor__BDNF__and_Cerebral_Dopamine_Neurotrophic_Factor__CDNF__by_Anti_Parkinsonian_Drug_Therapy_In_Vivo_Gyárfás T, Knuuttila J, Lindholm P, et al. 
Regulation of Brain-Derived Neurotrophic Factor (BDNF) and Cerebral Dopamine Neurotrophic Factor (CDNF) by Anti-Parkinsonian Drug Therapy In Vivo. [JOURNAL ARTICLE]
Cell Mol Neurobiol 2009 Sep 24.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19753135/full_citation/Role_of_rasagiline_in_treating_Parkinson's_disease:_Effect_on_disease_progression_Malaty IA, Fernandez HH 
Role of rasagiline in treating Parkinson's disease: Effect on disease progression. [Journal Article]
Ther Clin Risk Manag 2009 Aug; 5(4):413-9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19704083/full_citation/Dopamine_agonists_in_6_pyruvoyl_tetrahydropterin_synthase_deficiency_Porta F, Mussa A, Concolino D, et al. 
Dopamine agonists in 6-pyruvoyl tetrahydropterin synthase deficiency. [Comparative Study, Journal Article]
Neurology 2009 Aug 25; 73(8):633-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19702528/full_citation/Structure_Function_Regulation_and_Polymorphism_of_Human_Cytochrome_P450_2A6_Di YM, Chow VD, Yang LP, et al. 
Structure, Function, Regulation and Polymorphism of Human Cytochrome P450 2A6. [JOURNAL ARTICLE]
Curr Drug Metab 2009 Sep 1.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19687003/full_citation/Serotonin_toxicity_caused_by_moclobemide_too_soon_after_paroxetine_selegiline_Wu ML, Deng JF 
Serotonin toxicity caused by moclobemide too soon after paroxetine-selegiline. [Journal Article]
J Chin Med Assoc 2009 Aug; 72(8):446-9.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19646280/full_citation/A_Phase_1_Trial_of_pharmacologic_interactions_between_transdermal_selegiline_and_a_4_hour_cocaine_infusion_Harris DS, Everhart T, Jacob P, et al. 
A Phase 1 Trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. [JOURNAL ARTICLE]
BMC Clin Pharmacol 2009 Aug 1; 9(1):13.
Abstract | Full Citation | Find Related Articles